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ABSTRACT
A series of disubstituted 2-azaadamantanes representing confor
mational^ defined nitrogen mustards incorporated into an adamantyl
framework with fixed separation distances between alkylating centers
of 3.5 A. (2: 4,8-dichloro-2-azaadamantane) and 2.5 A (2: 4,9-
dichloro-2-azaadamantane; 3: 4, 10-dichloro-2-azaadamantane) have been
synthesized (Henkel et al., (1981) J. Org. Chem. , kb_, 3483 and
unpublished results) as rigid probes of DNA alkylation and crosslink-
ing processes leading to cytotoxicity.
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4,8 dichloro-2-aza 4,9 dichloro-2-aza 4,10 dichloro-2-aza
adamantane adamantane adamantane
The extent of intermolecular DNA crosslinking by the N-methyl isomer
series has been measured by an ethidium bromide fluorescence assay.
Results indicate that isomers 1 and 2 form intermolecular DNA cross
links, while 3 does not. Analysis of the kinetics of the reaction
isotherms of 1 and 2 indicate significant differences in their rates
and stability of crosslink formation. Crosslink reactions using DNAs
of different base composition have established that the extent of
crosslinking increases with increasing (G + C) content; however, the
(G + C) dependence on crosslinking varies substantially between 1 and
2, and between the isomers and nitrogen mustard itself. A relation
ship also appears to exist between the cytotoxic activity and stereo
chemistry of the isomers, which may indeed reflect differences in the
crosslinking behavior at the molecular level, and which may lead to
further elucidation of the molecular mechanism of action of both the
chloroethylnitrosoureas and the nitrogen mustards.
INTRODUCTION
Relatively few agents have been discovered which have been
useful in Central Nervous System (CNS) tumor chemotherapy (Henkel,
1983). Today, the most important class is the nitrosoureas, the
principle members of which are l-chloroethyl-3-cyclohexyl-l-nitro-
sourea (CCNU) and 1 ,3-Bis-chloroethyl-l-nitrosourea (BCNU) (Edwards
et al., 1980; Walker, 1973). These compounds exhibit their antitumor
activity in a complex manner, which involves both alkylation and
carbamoylation activities (Wheeler, 1975). However, it is now well
established that the major antitumor activity displayed by these
compounds can be attributed to the alkylation of nuclear macromole-
cules (Colvin et al. , 1976), followed by the formation of interstrand
crosslinks in the DNA (Kohn, 1977; Erikson et al. , 1980). The
interstrand crosslinking of DNA is a lethal event to the cell compar
ed with monoalkylation, since the latter is repaired more easily in
vivo prior to replication (Joshua et al. , 1980).
Previous studies have established correlations between anti
leukemic activity of mitomycin C and some aziridinoquinones and their
efficiency of DNA crosslinking (Akhtar et al. , 1975; Lown, 1979).
These correlations strongly suggest that measurements of DNA cross-
linking may be useful in the pre-screening of other potential antitu
mor agents, particularly those of the nitrogen mustard class. There
is a substantial body of knowledge concerning the mechanisms of
action of the N-mustards, and it is now well accepted that DNA
crosslinking is the primary cytotoxic event (Connors, 1974). The
crosslinking mechanism for mechlorethamine, HN , a N-mustard proto
type is illustrated in Figure 1.
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Figure 1. Crosslinking Mechanism for Mechlorethamine
This mechanism proceeds via a two-step process, requiring an initial
activation of the substrate through an anchimeric effect of the
nitrogen to yield an aziridium ion intermediate, a, alkylation of a
by cellular nucleophiles form the covalent link, b, after which a
second activation and alkylation step establishes the five atom
crosslink, c, to a neighboring nucleophilic center. If alkylation
occurs at nucleic acid base pairs located on opposite DNA strands,
then an interstrand covalent crosslink is produced. The potential
distance over which this crosslink occurs will be a function of (1)
the molecular distance between the second alkylating center and the
first alkylated nucleophile (approximately 4-5 A) and (2) the degrees
of conformational freedom available at the aziridium end of the
second intermediate over a range of directions.
Presumably, a portion of the observed antitumor non-selectively
and relatively high toxicity of the N-mustards (Thomas et al. , 1978)
is due to the mobility of the aziridium end of the second intermedi-
ate. Such conformational mobility could account for both the cyto
toxic non-selective alkylation of other macromolecules and the more
rapid DNA crosslinking by these agents, which appears to be enzymat-
ically repaired in vivo at later times during the cell cycle.
Consequently, there appears to be a requirement for both stereospeci-
fic DNA crosslinking and a delayed second alkylation step in order to
minimize cytotoxicity while enhancing crosslinking antitumor activi
ty. In addition, the alkylating agent must possess a high degree of
lipophilicity for transport across the cell walls (Levin et al. ,
1974; Henkel, 1983).
A series of potential CNS antitumor agents have been recently
synthesized which may exhibit DNA crosslinking activity as part of
their antitumor activity (Henkel, 1983). In this series of com
pounds, a nitrogen mustard moiety has been incorporated into the
hydrophobic framework of various azaadamantane isomers, 1, 2, and 3.
(See Figure 2.)
f-f^-N-R
V
!%?"
1 2 3
4,8 dichloro-2-aza 4,9 dichloro-2-aza 4,10 dichloro-2-aza
adamantane adamantane adamantane
where, X = Cl; R = CH3
Figure 2. Dichloro-N-Methyl-Azaadamantane Isomers
Although biological assays are currently being performed on
these isomers to determine their CNS antitumor effectiveness and
membrane permeability, in vivo, no experimental data has been report
ed on the mechanisms of their action with DNA with regard to molecu
lar crosslinking. It is the purpose of this study to quantitate the
extent of molecular crosslinking of these isomers with duplex DNA.
Molecular crosslinking was measured using a sensitive fluorometric
assay involving Ethidium Bromide with alkaline DNA denaturation. We
have also monitored, under a variety of reaction conditions, the
molecular crosslinking kinetics for these isomers in addition to
their potential DNA base content specificity. From the results of
this study, a correlation is made of the cytotoxic activity of these
compounds with their DNA crosslinking properties.
EXPERIMENTAL
The synthesis and toxicological properties of compounds 1, 2,
and 3 have been previously described (Henkel, 1983). These compounds
were kindly provided by Dr. James Henkel, Department of Medicinal
Chemistry, University of Connecticut. The molecular weights of the
isomers (compounds 1, 2, and 3) and HN are 256.5 and 192.5 grams per
mole, respectively. Ethidium Bromide was purchased from Sigma and
has a molecular weight of 394.3 grams per mole, and an extinction
coefficient of 5450 1 moles cm at 480 nm (Sigma). The DNA's used
in these experiments were Calf-Thymus (Type I, polymeric), E. Coli
(M.W. = 1.64 x 107, (G + C) = 50.0%, e(258) = 6500 1/moles-cm),
Micrococcus Luteus (M.W. = 1.9 x 10 , (G + C) = 72.0%, e(258) = 7040
1/moles-cm), and Calf-Thymus (M.W. = 9.0 x 106, (G + C) = 40.0%,
e(258) = 6500 1/moles-cm) (Sigma). All DNAs were purchased from
Sigma. All DNAs were prepared using a 20 mM potassium phosphate
solution at pH = 7, containing 0.15 M NaCl.
The four most commonly employed methods for determining the
frequencies of crosslinks in DNA is as follows: (1) visualization of
the DNA using electron microscopy under totally denaturing conditions
(Hansen et al. , 1976; Cech et al. , 1977); (2) sedimentation of DNA in
alkaline sucrose gradients (Cole and Zusman, 1970); (3) alkaline gel
electrophoresis (Cech, 1981); (4) alkaline denaturation/renaturation
(Geiduschek, 1961; Cole, 1970; Dall'Acqua et al. , 1970). Because one
crosslink is sufficient to hold complementary DNA strands in register
during the denaturation process and serve as a nucleation site for
complementary DNA strands to renature spontaneously after a cooling
period, the latter method cannot be used to differentiate between
singly crosslinked and multiply crosslinked DNA molecules (Cech,
1981). A modification of the alkaline denaturation/renaturation
procedure based on the fluorescent properties of the Ethidium dye
(Lown et al., 1976) was used to measure the interstrand crosslinking
which occurs between the azaadamantane isomers and duplex DNA.
Ethidium Bromide binds by intercalation into duplex DNA, which
results in an enhancement of fluorescence (LePecq and Paoletti,
1967) . Upon heat denaturation of duplex DNA in the presence of
Ethidium Bromide, the fluorescence enhancement will fall to zero
providing that one uses high pH in order to prevent the formation of
regions of self-complementarity (Morgan and Paektau, 1972). If one
crosslink is introduced by the action of alkylating agents, such as
HN , a return of Ethidium fluorescence is observed even under alka
line conditions after denaturation since this crosslink serves as a
nucleation site for the spontaneous renaturation of the DNA after a
heating and cooling cycle (Lown et al. , 1976).
The protocol for the Ethidium fluorescence assays is shown in
Figure 3 (Morgan and Pulleybank, 1974; Akhtar et al. , 1975; Morgan
and Paetkau, 1972).
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Figure 3. Protocol for Ethidium fluorescence assay
Assay Method
Calf-Thymus DNA (Type I, polymeric) was used in all direct
pellet reactions. A 20 mM potassium phosphate solution at pH = 7 ,
-4
containing 0.15 M NaCl and 2 x 10 M DNA-phosphate was used in these
experiments. All reactions were performed at ambient temperature.
Reactions were initiated at t = t , by addition of a previously
weighed sample of the crosslinking agent contained in a micro-capsule
dropped into the reaction vessel containing the DNA solution.
Approximately one to one and half milligrams of the crosslinking
agent was used for each reaction. All drugs were weighed on a
Mettler Analytical Microbalance using a microcapsule. Forty microli
ter aliquots were removed from the reaction solution at different
time intervals and added to one milliliter of Standard Ethidium
Bromide assay solution. This solution contains 20 mM potassium
phosphate, pH = 11.4, 0.2mM EDTA, and 0.5 lig/ml of Ethidium Bromide
(Lown et al. , 1978). All samples were mixed on a Vortex mixer and
then centrifuged for one minute on a Fisher Microcentrifuge. The
fluorescence of all samples was measured on a Perkin-Elmer Fluores
cence Spectrophotometer MPF 3L with excitation and emission wave
lengths set at 520 and 590 nanometers respectively. All samples were
subsequently heat denatured for three minutes at 97C in a Fisher
High Temp Bath Model 160 and cooled to 23C for five minutes (Lown et
al. , 1978). All samples were then allowed to reach ambient tempera
ture (approximately fifteen minutes) . The samples were then re-
centrifuged for one minute and the fluorescence re-measured under the
conditions described earlier.
The pre-dilution method is a homogeneous reaction. Previously
weighed crosslinking agents were pre-diluted in 20 mM phosphate
buffer at pH = 7, containing 0.15 M NaCl solution for three minutes
prior to initiating the crosslinking reaction. Reactions were
initiated at t = t by mixing equal volumes (200 ul) of the cross-
o
linking agent and DNA stock solutions at twice the reaction concen-
trations. Reactions were performed using a 20 mM phosphate solution
at pH = 7, containing 0.15 M NaCl and 1.5 x 10 M DNA-phosphate.
Forty microliter aliquots were removed from the reaction mixture at
specific time intervals and added to one milliliter of Standard
Ethidium Bromide assay solution. This solution contains 20 mM
potassium phosphate, pH = 11.4, 0.2 mM EDTA, and 0.5 Ug/ml of
Ethidium Bromide (Lown, et al. , 1978). All samples were treated
identically to those samples obtained in the direct pellet method and
all data obtained from these experiments were treated in the same
manner as in the direct pellet method, however, the percent cross-
linked was converted to the number of links per nucleotide for those
DNAs of known molecular weight.
Under the conditions described in the preceding paragraphs, only
the covalently crosslinked complementary DNA shows a return of
Ethidium fluorescence, since the covalent crosslink provides a
nucleation site for the spontaneous renaturation of the DNA (Lown et
al., 1976). Thus, the ratio of Ethidium fluorescence after heating
to the Ethidium fluorescence before heating, after correction for the
assay control blank, is proportional to the extent of the covalent
crosslinking of the DNA (Lown et al. , 1978).
Fluorescence Measurements
The fluorescence of all samples was measured on a Perkin-Elmer
Fluorescence Spectrophotometer MPF 3L using 0.2 cm fluorescence
cells. The one centimeter pathlength was placed in the excitation
beam. Excitation and emission wavelengths were set at 520 and 590
nm, respectively. The sensitivity was usually set at 10 and the scan
rate at 3 nm/second. The instrument was in the ratio mode during all
fluorescence measurements. All fluorescence measurements were
obtained at ambient temperature.
With the excitation wavelength set at 520 nm, the emission
spectra was scanned from 540 to 640 nm. In addition, fluorescence
measurements were obtained at the maximum emission wavelength, that
is, at 590 nm and blanked to the standard Ethidium Bromide assay
solution alone. A standard solution of Ethidium Bromide served as an
internal instrument reference.
Analysis of Fluorescence Data
As previously described, the ratio of Ethidium fluorescence
after heat denaturation to Ethidium fluorescence before heat denatura
tion (when corrected for the control blank) is proportional to the
extent of crosslinked DNA. For polymeric, Type I Calf-Thymus DNA, of
unknown molecular weight, this ratio is reported as the fluorescence
percent crosslinked DNA. However, this ratio does not equal the
actual number of crosslinks per DNA molecule since only one crosslink
per DNA molecule is sufficient to produce rapid renaturation after
cooling and more than one crosslink per DNA may be present and not
detected by this technique. Furthermore, the DNA segments may have
an unequal distribution of molecular weights rendering a calculation
of the number of DNA molecules impossible.
For DNA's of specific (G + C) content and known molecular
weight, crosslinking data is reported as the average number of
crosslinks per nucleotide, as calculated from the corrected number of
crosslinks per DNA molecule. Allowance was made for difference in
the average molecular weight of the different DNAs, DNAs of lower
molecular weight require more crosslinking events per nucleotide
residue to produce the same percentage of crosslinked DNA. Assuming
a Poisson distribution of links, and further that one crosslink is
sufficient to permit spontaneous renaturation of the molecule, the
corrected average number of crosslinks per DNA molecule, M (M = ln
(1/P ) where P is the proportion of unlinked molecules) was computed
(Hatchard, 1956), and correlated to the actual number of crosslinks
per nucleotide residue using the duplex concentration and the average
molecular weight.
RESULTS AND DISCUSSION
Heterogeneous (Direct Pellet) Reactions with Polymeric,
Type I, Calf-Thymus DNA
The intermolecular crosslinking studies of 1, 2, and 3 with high
molecular weight calf-thymus DNA have clearly established that both 1
and 2 form interstrand DNA crosslinks (in vitro) under physiological
conditions of temperature, pH and salt concentration, whereas no
interstrand crosslinking activity can be detected for 3 under similar
reaction conditions. The reaction profiles shown in Figures 4 and 5,
were from heterogeneous reactions in which the crystalline form of
the crosslinking agent was added directly to the DNA in aqueous
buffered solution.
As shown in Figures 4 and 5, the extent of interstrand cross-
linking associated with isomers 1 and 2 is both time-dependent and
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Figure 4. Time Dependent Crosslinking of Mechlorethamine, 4,9-
dichloro-2-methyl-2-azaadamantane and 4 , 8-dichloro-2-methyl-2-azaada-
mantane with Calf-Thymus DNA (Polymeric Type I); Direct Pellet Method.
D/P = 10.
Reactions were performed at 37C in a total volume of 10 ml buffered
with 20 mM potassium phosphate at pH = 7, 0.15 M NaCl, containing 2 x
4
10 DNA-phosphate. Reactions were initiated at t = t , by the direct
addition of a previously weighed sample of drug contained in a micro
capsule dropped into the reaction vessel containing the DNA solution.
Aliquots of 40 ul were withdrawn from the reaction solution at in
tervals, and analyzed for the extent of crosslinking by the addition
of one milliliter of standard pH = 11.4 ethidium bromide assay so
lution. Samples were subsequently heat denatured for 3 minutes at
97C and cooled to 23C. Under these conditions, only covalently
linked complementary DNA shows a return of fluorescence (Ethidium
Fluorescence) since the covalent links provide a nucleation site for
renaturation. The ratio of ethidium fluorescence after heating to the
fluorescence before heating is proportional to the extent of covalent
crosslinking of the DNA.
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Figure 5. Time Dependent Crosslinking of Mechlorethamine, 4,9-
dichloro-2-methyl-2-azaadamantane and 4,8-dichloro-2-methyl-2-azaada-
mantane with Calf-Thymus DNA (Polymeric Type I); Direct Pellet Method.
D/P = 5.
As per Figure 4, at drug/nucleotide-P ratio of 5:1.
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sensitive to the drug to nucleotide reaction stoichiometry. The
kinetics of the reaction profile of the 4,8-dichloro-N-methyl isomer
(I) are similar to the kinetics associated with the mechlorethamine
(HN^) control, forming crosslinks that are complete after approxi
mately ten minutes. However, the maximal extent of crosslinking for
1 at saturation appears to be approximately 40% of that for HN . In
contrast, both the reaction kinetics and the extent of crosslinking
of 2 differ significantly from 1. Specifically, the initial kinetics
of the crosslinking reaction for 2 are considerably more rapid than
the kinetics associated with 1. Also, at sufficiently high D/P
ratios the maximal extent of crosslinking for 2 parallels that of HN
(Figure 4). In addition, an unusual time-dependent decrease in
crosslinking is observed for 2 at reaction intervals greater than
three minutes. Both the extent of initial crosslinking and the
associated time-dependent decrease in crosslinking of 2 appear to be
sensitive to the reaction stoichiometry (Figures 4 and 5).
The extent of intermolecular crosslinking for HN does not
appear to be directly proportional to reaction stoichiometry under
the conditions of Figures 4 and 5. However, at drug to phosphate
ratios of 2:1 or lower, the extent of intermolecular crosslinking
does become proportional to the reaction stoichiometry (data not
shown) . This is due to the elimination of the saturation effects
which are evident at higher D/P ratios. Saturation for HN appears
to be approximately fifteen minutes (data not shown) at D/P less than
or equal to 2. The extent of intermolecular crosslinking for the 4,8
isomer appears to be directly proportional to the reaction stoichio-
15
metry at D/P ratios of 10:1 or lower. Saturation for the 4,8 isomer
appears to be approximately six minutes. The maximal extent of
intermolecular crosslinking of the 4,9 isomer is also found to
decrease with decreasing D/P ratios, however, not proportionally.
Homogeneous (Pre-Dilution) Reactions with Polymeric
Type I, Calf-Thymus DNA
Due to the observed time-dependent solubilization of HN and the
various isomers in aqueous solution, and to facilitate more quantita
tive measurements of DNA crosslinking studies with highly purified
DNAs of different (G + C) content, considerable time was devoted to
the development of an assay protocol to measure crosslinking under
homogeneous reaction conditions. A method was developed to initiate
the crosslinking reaction under conditions in which both DNA and the
crosslinking agent were in aqueous solution. Reactions would then be
homogeneous, eliminating the kinetics associated with the solubiliza
tion of the different crosslinking compounds. For all reactions
subsequent to Figures 4 and 5, the crosslinking agent was pre-
dissolved and pre-equilibrated in reaction buffer for exactly three
minutes before initiating the crosslink reaction by mixing equal
volumes of aqueous DNA with aqueous crosslink agent.
As illustrated by comparison of Figures 4 and 6, the reaction
kinetics and the extent of crosslinking of HN and 1 do not appear to
be significantly changed by introducing these compounds as aqueous
components into the DNA reaction solution. These results clearly
indicate that the solubilization rate of HN and 1 are considerably
shorter than that of the crosslinking kinetics. Compound 2 does,
16
Figure 6. Time Dependent Crosslinking of Mechlorethamine, 4,9-
dichloro-2-methyl-2-azaadamantane and 4 , 8-dichloro-2-methyl-2-azaada-
mantane with Calf-Thymus DNA (Polymeric Type I): Pre-Dilution Method.
D/P = 10, [Nucleotide-P] = 0.15 mM, time dissolved = three minutes.
Reactions were performed at 37CC, pH = 7 (20 mM phosphate buffer),
4
0.15 M NaCl containing 1.5 x 10 M DNA-phosphate. Reactions were
initiated at t = t by mixing equal volumes of drug and DNA stock
solutions at twice the reaction concentrations. Drugs were pre-
dissolved in buffer solution prior to initiating the crosslinking
reaction for three minutes.
17
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however, show a reduction in the extent of crosslinking when intro
duced in aqueous form (at identical D/P ratios), but the reaction
kinetics appear to be similar to those observed for 2 in the hetero
geneous reaction. These results would suggest that the rate of
solubilization and/or the life-time associated with the reactive
intermediate form of 2 does influence the overall extent of observed
crosslinking for this compound. As shown in Figures 6 and 7, when 1
and 2 axe introduced to the reaction in aqueous form after dissolving
for a three-minute period, the maximal extent of crosslinking is
similar (approximately 40% that of HN ) for both isomers, while the
reaction kinetics of 2 remains enhanced 3-4 fold as compared to the
crosslinking kinetics of 1 or HN .
Comparison of the HN profiles in Figures 6 and 7 illustrates
that at sufficiently low D/P ratios, the maximal extent of crosslink
ing occurs at longer reaction times and becomes proportional to the
HN /DNA reaction stoichiometry at D/P ratios below 2:1 (data not
shown) . Subsequent crosslinking experiments were therefore performed
at HN /DNA ratios of 1:1. Comparison of the 4,8 and 4,9 isomers'
reaction profiles in Figures 6 and 7, indicate that the extent of
crosslinking for these isomers also decrease with decreasing ratios
of drug to DNA and become proportional to the reaction stoichiometry
at D/P ratios of 4:1 or lower (see Tables 1 and 2). DNA content
dependence experiments were therefore performed at drug to DNA ratios
of 4:1.
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Figure 7. Time Dependent Crosslinking of Mechlorethamine, 4,9-
dichloro-2-methyl-2-azaadamantane and 4 , 8-dichloro-2-methyl-2-azaada-
mantane with Calf-Thymus DNA (Polymeric Type I): Pre-Dilution Method.
D/P = 2, [Nucleotide-P] = 0.15 mM, time dissolved = three minutes.
As per Figure 6, at drug/nucleotide ratio of 2:1.
20
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Table 1
Crosslinking Data for 4,8-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Co erected Number
(minutes) Crosslinked Un--Crosslinked of Crosslinks /DNA
2.0 0.076 0.924 0.079
4.0 0.098 0.902 0.103
6.0 0.123 0.874 0.132
10.0 0.130 0.870 0.139
15.0 0.137 0.863 0.147
Homogeneous reactions were performed at 37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7, 0.15 M NaCl, containing 1.5 x 10 M DNA. Drug: Phosphate
ratio was 2.
Table 2
Crosslinking Data for 4,8-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Co:erected Number
(minutes) Crosslinked Un-Crosslinked of Crosslinks /DNA
1.0 0.135 0.865 0.145
2.0 0.205 0.795 0.229
3.0 0.265 0.735 0.308
4.0 0.308 0.692 0.368
6.0 0.327 0.673 0.396
10.0 0.306 0.694 0.365
14.0 0.296 0.704 0.351
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7, 0.15 M NaCl, containing 1.5 x 10 M DNA. Drug: Phosphate
ratio was 4.
The
"apparent" decrease in the extent of crosslinking of the 4,9
isomer at longer reaction times (4 minutes or longer) as observed in
Figures 4-7 deserves special comment. At longer reaction times, the
extent of crosslinking of the 4,9 isomer appears to decrease even
22
though the DNA prior to denaturation, under alkaline conditions,
remains double-stranded as indicated by Ethidium fluorescence. It is
possible that the 4,9 isomer crosslinked DNA may be more susceptible
to heat induced depurination under alkaline conditions which may
account for this unusual decrease in "measurable" crosslinks.
Alternatively, it is possible that the 4,9 crosslink is either
unstable or in some manner produces single strand breaks in the DNA
rendering the crosslink undetectable by this technique. The nature
of this decreased crosslinking is currently under investigation.
Dependence of (G + C) DNA Base Content Crosslinking Efficiency
Using highly purified DNAs of known (G + C) base content and
with established molecular weights (as measured by sedimentation
analyses) , we can now report the extent of interstrand crosslinking
by HN , 1 , and 2 in terms of the average number of crosslinks per
nucleotide, in addition to the base-sequence dependence of this
crosslinking as a function of DNA (G + C) content. For example, HN
at 1.5 x
10~4
M gives 2.9 x , 5.1 x , 6.5 x , and 5.0 x
interstrand crosslinks per nucleotide at saturation with DNAs of
(G + C) content of 26.5, 40, 50, and 72%, respectively (Figures 8 and
9). The extent of HN crosslinking (at saturation) and its (G + C)
dependence are comparable to the interstrand crosslinking activity of
Mitomycin C (Lown et al., 1976) and to the photo-induced crosslinking
activity of psoralen and other furocoumarins with nucleic acids (Lown
et al. , 1978). This (G + C) dependent behavior is indicative of
preferential crossslinking at guanine and/or cytosine residues. At
23
Figure 8. Crosslinking Reaction Profile of Mechlorethamine (HN ) with
Defined Molecular Weight DNAs of Different (G + C) Content.
Pre-Dilution Method: D/P = 0.82, [Nucleotide-P] = 0.18 mM, time
dissolved = three minutes.
As per Figure 6, at drug/nucleotide ratio of 0.82:1 (all ratios scaled
to constant D/P = 1.0). DNA molecular weights were determined by
sedimentation velocity studies, which allow for the direct calcula
tions of the average number of crosslinks per nucleotide residue. The
DNAs used were Clostridium Perfringens (M.W. = 2.0 x 10 , (G + C) =
26.5%, e(258) = 6300 1/moles-cm), Calf-Thymus (M.W. = 9.0 x 10 ^ (G
+
C) = 40%, e(258) = 6420 1/moles-cm), E. Coli (M.W. = 1.64 x 10 , G +
C) = 50%, e(258) = 6500 1/moles-cm).
24
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Figure 9. (G + C) Dependence of the Efficiency of Crosslinking of DNA
by HN2-
Pre-Dilution Method: D/P = 0.82, [Nucleotide-P] = 0.18 mM, time
dissolved = three minutes ( all ratios scaled to constant (D/P = 1:1).
Data from Figure 8 representing (G + C) dependence of DNA crosslinking
by HN at various reaction time intervals.
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saturation, the extent of crosslinking for HN appears to be directly
proportional to the (G + C) content from 25 to 50%, and levels off or
decreases to some extent beyond 50% (G + C) content. The initial
rate of crosslinking increases from 1.25 x crosslinks /nucleo-
tide-min to 8.8 x
'
crosslinks /nucleotide-min from 26.5 to 50% (G
+ C) DNA content, respectively. This represents a 7-fold enhancement
in crosslinking kinetic efficiency for HN with increasing (G + C)
content from 26.5 to 50%.
Although both 1 and 2 clearly show (G + C) DNA content depen
dence in their crosslinking efficiencies, these isomers differ
significantly with regard to both the characteristics of their
base-sequence dependence and the kinetics of their (G + C) dependent
crosslinking efficiency (Figures 10-13). The crosslinking reaction
profiles of HN , 2, and 1 with DNAs of different (G + C) content are
shown in Figures 8, 10, and 12, respectively. The (G + C) dependence
of the efficiency of crosslinking for these compounds are shown in
Figures 9, 11, 13, as a function of various reaction time intervals.
-4
The 4, 9-dichloro-N-methyl isomer, 2, at 6.6 x 10 M gives 1.4 x
, 6.0 x 10 , > 9.0 x 10 interstrand crosslinks per nucleotide
at maximum measurable crosslinking (time approximately 3 minutes)
with DNAs of (G + C) content of 26.5, 50, and 72%, respectively
(Figures 10 and 11), while under similar reaction conditions the
-5 -5
4,8-dichloro-N-methyl isomer, 1, gives 0.44 x 10 , 1.2 x 10 , and
0.7 x 10 interstrand crosslinks per nucleotide at saturation (time
approximately six minutes) for 26.5, 50, and 72% (G + C) content.
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Figure 10. Crosslinking Reaction Profile of 4,9-dichloro-2-methyl-
2-azaadamantane with defined Molecular Weight DNAs of Different (G +
C) content.
Pre-Dilution Method: D/P = 3.28, [Nucleotide-P] = 0.2 mM, time
dissolved = three minutes.
As per Figure 8, at a drug/nucleotide ratio of 3.28:1 (all ratios
scaled to constant D/P ratio = 4) .
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Figure 11. (G + C) Dependence of the Efficiency of Crosslinking of
DNA by 4,9-dichloro-2-methyl-2-azaadamantane.
Data from Figure 10 representing (G + C) dependence of DNA crosslink
ing by the 4,9 isomer at various time intervals during the reaction,
up to the onset of the time-dependent decrease in measured crosslink
ing.
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Figure 12. Crosslinking Reaction Profile of 4,8-dichloro-2-methyl-
2-azaadamantane with defined Molecular Weight DNAs of Different (G +
C) content.
Pre-Dilution Method: D/P = 3.28, [Nucleotide-P] = 0.2 mM, time
dissolved = three minutes.
As per Figure 8, at a drug/nucleotide ratio of 3.28:1 (all ratios
scaled to constant D/P ratio = 4).
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Figure 13. (G + C) Dependence of the Efficiency of Crosslinking of
DNA by 4,8-dichloro-2-methyl-2-azaadamantane.
Data from Figure 12 representing (G + C) dependence of DNA crosslink
ing by the 4,8 isomer at various reaction time intervals.
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Due to the time-dependent decrease observed in the crosslinking
reaction for 2, it is important to note that the absolute extent of
crosslinking at saturation cannot be measured for this isomer. As a
result, direct comparisons of the overall extent of crosslinking
between 1 and 2 can only be made for identical reaction time inter
vals and/or from initial rates of crosslinking for time intervals
preceding the observed decrease in crosslinking. Analysis of the
initial crosslinking rates of 1 and 2 for Clostridium Perfringens DNA
(26.5% G + C) and E. Coli DNA (50% G + C) from Figures 12 and 10,
respectively, indicate a 14-fold enhancement in the initial cross-
linking rate for 1. Furthermore, 2 appears to be considerably more
specific with regard to its (G + C) dependence showing increased
crosslinking with increased (G + C) content. In contrast, 2 shows
both a (G + C) dependence and (A + T) dependence of approximately
equal magnitudes. This is evident from Figure 13, in that the
decrease in (G + C) dependent crosslinking for (G + C) contents
greater than 50% are equally indicative of an (A + T) dependent
increase in crosslinking for (A + T) up to 50%. One could therefore
conclude that the 4,8 isomer may have increasing (G + C) and (A + T)
dependencies up to 50% base pair content.
The (G + C) content dependent crosslinking of the 4,8 and 4,9
isomers may be associated with alkylation at specific sites on the
pyrimidine or purine bases as is observed with the preferential
crosslinking of HN at the N-7 guanine position (Brookes and Lawley,
1961). However, at the present time, it is impossible to distinguish
if alkylation is occurring uniquely at purine or pyrimidine residues
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or across purine/pyrimidine base pairs. The differences observed in
the (G + C) content dependent crosslinking of the 4,8 and 4,9 isomers
are most probably associated with the stereochemistry of these
isomers and may indeed reflect stereospecif ic crosslinking selectivi
ty.
Correlation of Cytotoxic Activity with Molecular Crosslinking
The cytotoxic activity of these compounds was determined by
investigating the effect of these compounds on the viability of a
neoplastic cell line in vitro. The KB 9 cell line, derived from a
human carcinoma of the nasopharynx was chosen for the initial
screening of the compounds. The test compounds were added to previ
ously plated KB 9 cells. Controls consisted of the addition of
saline in the place of the drug solution to the cell cultures. The
increase in the cell colony number of the controls and test cultures
were determined following 7-8 days of growth. Table 3 contains
estimated ID values based on probit analysis of the dose-response
data resulting from the percent inhibition in the drug-treated cell
cultures relative to the controls.
Table 3
Cytotoxic Activity of the 4,8 and 4,9-disubstituted
Series Expressed as IDsf) (M)
R 4,8-isomer 4,9-isomer 4,9/4,8 ratio
Hydrogen 13 (9-24)
Methyl 275 (234-354) 87 (49-113) 3.2
Isopropyl 208 (115-479) 62 (55-72) 3.4
Isoamyl 160 (141-186) 57 2.8
Benzyl 86 (71-102)
Mechlorethamine 0.066
(Henkel, et al. , 1983)
~
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All of the compounds tested in both the 4,8 and 4,9 series have
significant cytotoxic activity. Those compounds tested in the 4,10
series do not crosslink DNA and do not exhibit any cytotoxic activi
ty. Within the methyl series, the 4,9 isomer appears to exhibit
significantly more cytotoxic activity than the 4,8 isomer. It should
be noted that the 4,9 isomer produces crosslinks much more rapidly
than the 4,8 isomer and demonstrates a stronger (G + C) dependence
than the 4,8 isomer. A relationship appears to exist between the
potency of the cytotoxic activity and the stereochemistry of the
isomer series. Since the 4,8 and 4,9 isomers possess similar chemi
cal and physiochemical properties, the observed differences may
indeed reflect differences in the crosslinking behavior at the
molecular level. These results suggest that both the chemical nature
of the crosslink produced by bifunctional alkylating agents and the
stereochemical constraints of that crosslink on the DNA may greatly
influence the overall pharmacological behavior of the drug.
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Table 1
Crosslinking Data for Mechlorethamine
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Corrected Number
(minutes) Crosslinked Un-Crosslinked of Crosslinks /DNA
0.0 0.000 1.000 0.000
2.5 0.700 0.300 1.204
5.0 0.830 0.170 1.309
7.5 0.830 0.170 1.309
15.0 0.870 0.130 1.470
Table 2
Crosslinking Data for 4,8-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Corrected Number
(minutes) Crosslinked Un-Crosslinked of Crosslinks/DNA
0.0 0.000 1.000 0.000
2.5 0.300 0.700 0.357
5.0 0.430 0.570 0.562
7.5 0.450 0.550 0.598
15.0 0.430 0.570 0.562
Table 3
Crosslinking Data for 4, 9-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Corrected Number
(minutes) Crosslinked Un-Crosslinked of Crosslinks/DNA
0.0 0.000 1.000 0.000
1.0 0.380 0.620 0.478
2.0 0.770 0.230 0.109
3.0 0.770 0.230 0.109
5.0 0.790 0.210 0.561
7.0 0.510 0.490 0.713
15.0 0.300 0.700 0.357
Heterogeneous reactions were performed at
37 C in a total volume of
10 ml buffered with 20 mM potassium phosphate solution at pH equal to
7, 0.15 M NaCl, containing 2 x 10 M DNA. Drug: Phosphate ratio
was 10.
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Table 4
Crosslinking Data for Mechlorethamine
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Corrected Number
(minutes) Crosslinked Un--Crosslinked of Crosslinks/DNA
2.0 0.529 0.471 0.753
3.0 0.638 0.362 1.016
5.0 0.720 0.280 1.273
10.5 0.827 0.173 1.754
15.0 0.827 0.173 1.754
30.0 0.827 0.173 1.754
Table 5
Crosslinking Data for 4,8-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Corrected Number
(minutes) Crosslinked Un-Crosslinked of Crosslinks/DNA
2.0 0.035 0.965 0.036
3.0 0.200 0.800 0.223
5.0 0.168 0.832 0.184
10.0 0.207 0.793 0.232
15.0 0.224 0.776 0.254
30.0 0.136 0.864 0.146
Table 6
Crosslinking Data for 4,9-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Co:erected Number
(minutes) Crosslinked Un-Crosslinked of Crosslinks/DNA
2.0 0.509 0.491 0.711
3.0 0.573 0.427 0.851
5.0 0.490 0.510 0.673
10.0 0.352 0.648 0.434
15.0 0.433 0.567 0.567
30.0 0.228 0.772 0.259
Heterogeneous reactions were performed at
37 C in a total volume of
10 ml buffered with 20 mM potassium phosphate solution at pH equal to
7, 0.15 M NaCl, containing 2 x 10 M DNA. Drug: Phosphate ratio
was 5.
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Table 7
Crosslinking Data for Mechlorethamine
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Co:erected Number
(minutes) Crosslinked
0.813
Un-Crosslinked of Crosslinks/DNA
2.0 0.187 1.677
4.0 0.842 0.158 1.845
6.0 0.912 0.088 2.430
10.0 0.957 0.043 3.146
15.0 0.952 0.048 3.036
30.0 0.931 0.069 2.674
Tab].e 8
Crosslinking Data for 4,8-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Corrected Number
(minutes) Crosslinked Un--Crosslinked of Crosslinks/DNA
2.0 0.186 0.814 0.206
4.0 0.266 0.734 0.309
6.0 0.330 0.670 0.400
10.0 0.378 0.622 0.475
15.0 0.341 0.659 0.417
30.0 0.229 0.771 0.260
Tabl.e 9
Crosslinking Data for 4,9-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Corrected Number
(minutes) Crosslinked Un--Crosslinked of Crosslinks/DNA
2.0 0.359 0.641 0.445
4.0 0.385 0.615 0.486
6.0 0.331 0.669 0.402
10.0 0.277 0.723 0.324
15.0 0.218 0.782 0.246
30.0 0.192 0.808 0.213
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7, 0.15 M NaCl, containing 1.5 x 10 M DNA. Drug: Phosphate
ratio was 10.
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Table 10
Crosslinking Data for 4, 10-Dichloro-2-Methyl-2-Azaadamantane and
Calf-Thymus DNA (Type 1, Polymeric) - Drug: Phosphate = 10
Time Fraction Fraction Co:erected Number
(minutes) Crosslinked Un--Crosslinked of Crosslinks/DNA
2.0 -0.014 1.000 0.000
4.0 -0.014 1.000 0.000
6.0 0.000 1.000 0.000
10.0 -0.015 1.000 0.000
15.0 0.025 0.975 0.025
30.0 0.037 0.963 0.037
Table 11
Crosslinking Data for 4, 10-Dichloro-2-Methyl-2-Azaadamantane and
Calf-Thymus DNA (Type 1, Polymeric) - Drug: Phosphate = 2
Time Fraction Fraction
*
Corrected Number
(minutes) Crosslinked Un-Crosslinked of Crosslinks/DNA
2.0 0.131 0.868 0.141
4.0 0.079 0.921 0.083
6.0 0.099 0.901 0.104
10.0 0.073 0.927 0.076
15.0 0.078 0.922 0.081
30.0 0.079 0.921 0.082
Table 12
Crosslinking Data for 4, 10-Dichloro-2-Methyl-2-Azaadamantane and
Calf-Thymus DNA (Type 1, Polymeric) - Drug: Phosphate = 0.5:1
Time Fraction Fraction Corrected Number
(minutes) Crosslinked Un-Crosslinked of Crosslinks/DNA
2.0 0.032 0.968 0.032
4.0 0.065 0.935 0.067
6.0 0.060 0.940 0.062
10.0 0.062 0.938 0.064
15.0 0.056 0.944 0.058
30.0 0.089 0.911 0.093
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7, 0.15 M NaCl, containing 1.5 x 10 M DNA.
This data is suspect because the control did not denature properly.
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Table 13
Crosslinking Data for Mechlorethamine
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Corrected Number
(minutes) Crosslinked Un-Crosslinked of Crosslinks/DNA
2.0 0.411 0.589 0.529
4.0 0.569 0.431 0.842
6.0 0.663 0.337 1.088
10.0 0.753 0.247 1.398
15.0 0.856 0.144 1.938
Table 14
Crosslinking Data for 4,8-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA (Type 2, Polymeric)
Time Fraction
(minutes) Crosslinked
2.0 0.076
4.0 0.098
6.0 0.123
10.0 0.130
15.0 0.137
Fraction Corrected Number
Un-Crosslinked of Crosslinks/DNA
0.923 0.079
0.901 0.103
0.876 0.132
0.870 0.139
0.863 0.147
Table 15
Crosslinking Data for 4, 9-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Corrected Number
(minutes) Crosslinked Un-Crosslinked of Crosslinks/DNA
2.0 0.101 0.899 0.106
4.0 0.124 0.876 0.132
6.0 0.124 0.876 0.132
10.0 0.094 0.906 0.099
15.0 0.068 0.932 0.070
30.0 0.059 0.941 0.061
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7 0.15 M NaCl, containing 1.5 x 10 M DNA. Drug: Phosphate
ratio was 2.
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Table 16
Crosslinking Data for Mechlorethamine
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Co:erected Number
(minutes) Crosslinked Un-Crosslinked of Crosslinks/DNA
1.0 0.786 0.214 1.542
2.0 0.837 0.163 1.814
3.0 0.947 0.053 2.937
4.0 0.920 0.080 2.625
6.0 0.982 0.018 4.017
10.0 0.043 0.957 3.146
15.0 0.962 0.038 3.290
Table 17
Crosslinking Data for 4,8-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA (Type 1, Polymeric)
Time Fraction Fraction Co:erected Number
(minutes) Crosslinked Un-Crosslinked of Crosslinks/DNA
1.0 0.135 0.865 0.145
2.0 0.205 0.795 0.229
3.0 0.265 0.735 0.308
4.0 0.308 0.692 0.368
6.0 0.327 0.673 0.396
10.0 0.306 0.694 0.365
14.0 0.296 0.704 0.351
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7, 0.15 M NaCl, containing 1.5 x 10 M DNA. Drug: Phosphate
ratio was 4.
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Table 18
Crosslinking Data for Mechlorethamine
and Clostridium Perfringens DNA
Number of
Corrected Crosslinks/
Time Fraction Fraction Number of nucleotide
(x 10"b)(minutes) Crosslinked Un-Crosslinked Crosslinks/DNA
1.0 0.0738 0.9262 0.0766 1.345
2.0 0.1329 0.8671 0.1426 2.318
3.0 0.1946 0.8054 0.2164 3.518
4.0 0.2550 0.7450 0.2944 4.786
6.0 0.3691 0.6309 0.4606 7.487
10.0 0.5168 0.4832 0.7273 11.820
14.0 0.6026 0.3974 0.9228 15.000
120.0 0.8309 0.1691 1.7770 28.890
Lot #86C-6850; DNA m.w. 2.0 x 10 ; DNA - P 1.984
,-4
10 M; DNA - dup
3.23 x
10-7
M; drug/DNA 0.82; drug/DNA - dup 5.04 x 10 .
Table 19
Crosslinking Data for Mechlorethamine
and Calf-Thymus DNA
Time
(minutes)
Fraction
Crosslinked
Fraction
Un-Crosslinked
Corrected
Number of
Crosslinks/DNA
Number of
Crosslinks/
nucleotide
(x 10~b)
2.0 0.0870 0.9130 0.0910 3.288
3.0 0.1250 0.8750 0.1335 4.826
4.0 0.1913 0.8087 0.2123 7.668
6.0 0.2719 0.7281 0.3173 11.460
10.0 0.4210 0.5790 0.5464 19.740
14.0 0.4786 0.5214 0.6512 23.520
Lot //91F-6833; DNA m.w. 9.0 x IO6; DNA - P 8.576 x 10 ^M; DNA - dup
3.09 x 10 M; drug/DNA 1.82; drug/DNA - dup 5.04 x 10 .
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7, 0.15 M NaCl.
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Table 20
Crosslinking Data for Mechlorethamine
and Calf-Thymus DNA
Number of
Corrected Crosslinks/
Time Fraction Fraction Number of nucleotide
(x IO*6)(minutes) Crosslinked Un-Crosslinked Crosslinks/DNA
1.0 0.0942 0.9058 0.0989 3.573
2.0 0.1259 0.8741 0.1346 4.861
3.0 0.1655 0.8345 0.1809 6.535
4.0 0.2206 0.7794 0.2492 9.002
6.0 0.3094 0.6906 0.3719 13.370
10.0 0.4638 0.5362 0.6232 22.510
14.0 0.5357 0.4663 0.7672 27.710
60.0 0.8217 0.1786 0.7230 62.220
90.0 0.8222 0.1778 1.7270 62.380
120.0 0.8370 0.1630 1.8140 65.520
150.0 0.8188 1.1812 1.7080 61.700
Lot //91F-6833; DNA m.w. 9.0 x 106; DNA - P 1.577 x 10
4
M; DNA - dup
5.69 x 10 M; drug/DNA 1; drug/DNA - dup 2.77 x 10 .
Table 21
Time
(minutes)
Crosslinking Data for Mechlorethamine
and E. Coli DNA
Corrected
Fraction Fraction Number of
Crosslinked Un-Crosslinked Crosslinks/DNA
Number of
Crosslinks/
nucleotide
(x IO"6)
1.0
2.0
3.0
4.0
6.0
10.0
14.0
0.3364
0.5093
0.6551
0.7167
0.8246
0.9500
0.9083
0.6634
0.4907
0.3449
0.2833
1754
0.0500
0.0917
0
0.4104
0.7119
1.0640
1.2610
1.7410
2.9960
2.3890
8.134
14.110
21.090
34.990
34.510
59.380
47.350
-4
Lot //101F-6815: DNA m.w. 16.4 x 10 ; DNA - P 1.573 x 104 M; DNA -
dup 3.12 x 10 M; drug/DNA 1; drug/DNA
- dup 5.04 x 10 .
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7 and 0.15 M NaCl.
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Table 22
Crosslinking Data for Mechlorethamine
and E. Coli DNA (Trial 1)
Number of
Corrected Crosslinks/
Time Fraction Fraction Number of nucleotide
(x 10"6)(minutes) Crosslinked Un-Crosslinked Crosslinks/DNA
1.0 0.2074 0.7926 0.2324 4.606
2.0 0.3125 0.6875 0.3747 7.427
3.0 0.3606 0.6394 0.4472 8.864
4.0 0.4682 0.5218 0.6315 1.252
6.0 0.6136 0.3864 0.9509 18.850
10.0 0.7109 0.2891 1.2400 24.600
14.0 0.8110 0.1890 1.6660 33.020
Lot #101F-6815: DNA m.w,
10 M; drug;
, 16 .4 x IO6; DNA - P 1.573 x 10/
4
M; DNA -
dup 3. 12 x 'DNA 1; drug/DNA - dup 5.04 x
*
Table 23
Crosslinking Data for Mechlorethamine
and E. Coli DNA (Trial 2)
Time
(minutes)
Fraction
Crosslinked
Fraction
Un-Crosslinked
Corrected
Number of
Crosslinks/DNA
Number of
Crosslinks/
nucleotide
(x 10~6)
1.0 0.0465 0.9535 0.0476 1.160
2.0 0.0938 0.9062 0.0985 2.389
3.0 0.1231 0.8769 0.1314 3.187
4.0 0.1970 0.8030 0.2194 5.337
6.0 0.2923 0.7077 0.3457 8.388
10.0 0.3939 0.6061 0.5007 12.150
14.0 0.4463 0.5537 0.5911 14.340
Lot #72F-6836 DNA m.w. 13.4 x 10 ; DNA - P 1. 600 x 10 M; DNA -
dup 3.88 x M; drug/DNA 1; drug/DNA - dup 4.12 x 10 .
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7 and 0.15 M NaCl.
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Table 24
Crosslinking Data for Mechlorethamine
and M. Luteus DNA (Trial 1)
Number of
Corrected Crosslinks/
Time Fraction Fraction Number of nucleotide
(x 10"6)(minutes) Crosslinked Un-Crosslinked Crosslinks/DNA
1.0 0.4000 0.6000 0.5108 8.741
2.0 0.4710 0.5290 0.6368 10.890
3.0 0.5857 0.4142 0.8812 15.080
4.0 0.6712 0.3288 1.1120 19.032
6.0 0.8138 0.8620 1.6810 28.670
10.0 0.8919 0.1081 2.2250 38.070
14.0 0.9137 0.0863 2.4500 41.920
Lot #89C-6820; DNA m.w. 1.9 x 10?; DNA - P 1.854 x 10
4
M; DNA -
dup 3.17 x M drug/DNA 0.86; drug/DNA - dup 5.04 x 10 .
Table 25
Crosslinking Data for Mechlorethamine
and M. Luteus DNA (Trial 2)
Number of
Corrected Crosslinks/
Time Fraction Fraction Number of nucleotide
(x IO"6)(minutes) Crosslinked Un-Crosslinked Crosslinks/DNA
1.0 0.1780 0.8220 0.1960 3.350
2.0 0.3162 0.6838 0.3801 6.504
3.0 0.4250 0.5750 0.5534 9.469
4.0 0.4915 0.5085 0.6763 11.570
6.0 0.6271 0.3729 0.9864 16.880
10.0 0.7458 0.2542 1.3690 23.440
14.0 0.8136 0.1864 1.6790 28.740
60.0 0.8361 0.1639 1.8080 30.940
90.0 0.8702 0.1298 2.0420 34.940
120.0 0.9115 0.0885 2.4250 41.490
150.0 0.9174 0.0826 2.4940
42.610
Lot #89C- 6820 ;QDNAm.w.
M; drug
1.9 x 107; DNA - - P 1.562 x ,M; DNA
-
4
dup 2.67 x 10 /DNA 1; drug/DNA
- dup 5.84 x 10
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7 and 0.15 M NaCl.
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Table 26
Crosslinking Data for 4,8-Dichloro-2-Methyl-2-Azaadamantane
and Clostridium Perfringens DNA
Number of
Corrected Crosslinks/
Time Fraction Fraction Number of nucleotide
(x IO"6)(minutes) Crosslinked Un-Crosslinked Crosslinks/DNA
0.50 0.0559 0.9441 0.0575 0.934
1.00 0.0963 0.9037 0.1012 1.646
1.30 0.1293 0.8707 0.1384 2.251
2.00 0.1575 0.8424 0.1714 2.787
2.30 0.1862 0.8138 0.2060 3.350
3.00 0.2013 0.7987 0.2248 3.655
4.00 0.2053 0.7947 0.2298 3.736
6.00 0.2381 0.7619 0.2719 4.422
10.00 0.2148 0.7852 0.2418 3.932
14.00 0.1678 0.8322 0.1837 2.987
20.00 0.1409 0.8591 0.1619 2.469
60.00 0.0604 0.9396 0.0623 1.013
Lot #86C-6850; DNA m.w.
x 10 M; drug
2.Ox 107; DNA - P 1.984 x
io"4
M;,DNA -
To4.dup 3.23 /DNA 3.28; drug/DNA - dup 2. 01 x
Table 27
Crosslinking Data for 4,8-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA
Number of
Corrected Crosslinks/
Time Fraction Fraction Number of nucleotide
(x 10"6)(minutes) Crosslinked
0.0511
Un-Crosslinked Crosslinks/DNA
0.50 0.9489 0.0524 1.893
1.00 0.0652 0.9348 0.0674 2.435
1.30 0.0797 0.9203 0.0831 3.000
2.00 0.0942 0.9058 0.0989 3.574
2.30 0.1094 0.8906 0.1159 4.185
3.00 0.1143 0.8857 0.1214 4.390
4.00 0.1181 0.8819 0.1257 4.534
6.00 0.1888 0.8112 0.2092 7.558
10.00 0.2000 0.8000 0.2231 8.060
14.00 0.1857 0.8143 0.2054 7.420
6 -4
Lot #91F-6833; DNA m.w. 9.0 x 10 ; DNA - P 1.577 x 10 L; DNA -
dup 5.69 x M; drug/DNA 4; drug/DNA - dup 1.10 x 10 .
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7 and 0.15 M NaCl.
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Table 28
Crosslinking Data for 4,8-Dichloro-2-Methyl-2-Azaadamantane
and E. Coli DNA
Corrected
Time Fraction Fraction Number of
(minutes) Crosslinked Un-Crosslinked Crosslinks/DNA
Number of
Crosslinks/
nucleotide
(x IO"6)
1.00 0.1938 0.8062 0.2154 4.267
2.00 0.3258 0.6742 0.3942 7.814
3.00 0.4060 0.5940 0.5209 10.320
4.00 0.4436 0.5564 0.5863 11.620
6.00 0.4662 0.5338 0.6277 12.440
10.00 0.4286 0.5714 0.5597 11.090
14.00 0.3158 0.6842 0.3795 7.522
.-4
Lot #101F-6815: DNA m.w. 16.4 x 10"; DNA - P 1.573 x 10
"
M; DNA -
dup 3.12 x M; drug/DNA 4; drug/DNA - dup 2.01 x 10 .
Table 29
Crosslinking Data for 4,8-Dichloro-2-Methyl-2-Azaadamantane
and M. Luteus DNA
Number of
Corrected Crosslinks/
Time Fraction Fraction Number of nucleotide
(minutes) Crosslinked
0.0970
Un-Crosslinked Crosslinks/DNA (x 10 6)
0.50 0.9030 0.1020 1.746
1.00 0.0930 0.9070 0.0976 1.670
1.30 0.1504 0.8946 0.1630 2.789
2.00 0.1765 0.8235 0.1942 3.323
2.30 0.2353 0.7647 0.2683 4.590
3.00 0.2353 0.7647 0.2683 4.590
4.00 0.2797 0.7206 0.3277 5.607
6.00 0.3235 0.6765 0.3908 6.687
10.00 0.3433 0.6567 0.4205
7.195
14.00 0.3134 0.6866 0.3760
6.434
T.nf #89C-6 820: DNA m.w. 1.9 x 107; DNA - P 1.854 x
io"4
M; DNA -
dup 3.17 x
1019
M; drug/DNA 3.45; drug/DNA
- dup 2.01 x 10".
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at
pH equal
to 7 and 0.15 M NaCl.
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Table 30
Crosslinking Data for 4,9-Dichloro-2-Methyl-2-Azaadamantane
and Clostridium Perfringens DNA
Number of
Corrected Crosslinks/
Time Fraction Fraction Number of nucleotide
(x IO"6)(minutes) Crosslinked Un-Crosslinked Crosslinks/DNA
0.50 0.0199 0.9801 0.0201 0.326
1.00 0.0399 0.9601 0.0407 0.662
1.30 0.0519 0.9481 0.0533 0.866
2.00 0.0649 0.9351 0.0671 1.091
2.30 0.0633 0.9367 0.0654 1.063
3.00 0.0828 0.9172 0.0864 1.405
4.00 0.0633 0.9367 0.0654 1.063
6.00 0.0637 0.9363 0.0658 1.069
10.00 0.0253 0.9747 0.0256 0.417
14.00 0.0255 0.9745 0.0258 0.419
20.00 0.0127 0.9873 0.0128 0.208
Lot #86C- 6850; DNA m.w. 2.0 x 107; ]DNA - P 1.984 x
IO"4
M; DNA -
10 .dup 3.23 x M; drug/DNA 3.28; drug/DNA - dup 2.01 x
Table 31
Crosslinking Data for 4,9-Dichloro-2-Methyl-2-Azaadamantane
and Calf-Thymus DNA
Number of
Corrected Crosslinks/
Time Fraction Fraction Number of nucleotide
(x 10 6)(minutes) Crosslinked Un-Crosslinked Crosslinks/DNA
0.50 0.0511 0.9489 0.0324 1.893
1.00 0.0652 0.9348 0.0764 2.445
1.30 0.0797 0.9203 0.0831 3.000
2.00 0.0942 0.9058 0.0989 3.574
2.30 0.1094 0.8906 0.1159 4.185
3.00 0.1143 0.8857 0.1214 4.390
4.00 0.1181 0.8819 0.1257 4.539
6.00 0.1888 0.8112 0.2192 7.558
10.00 0.2000 0.8000 0.2231 8.060
14.00 0.1857 0.8153 0.2054 7.420
Lot #91F-6833; DNA m.w. 9.0 x IO6; DNA - P 1.577 x IO"4,.M; DNA -
dup 5.69 x 10 M; drug/DNA 4; drug/DNA
- dup 1.10 x 10 .
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7 and 0.15 M NaCl.
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Table 32
Crosslinking Data for 4,9-Dichloro-2-Methyl-2-Azaadamantane
and E. Coli DNA
Number of
Corrected Crosslinks/
Time Fraction Fraction Number of nucleotide
(x 10"6)(minutes) Crosslinked Un-Crosslinked Crosslinks/DNA
0.50 0.1804 0.8196 0.1989 3.943
1.00 0.2647 0.7353 0.3075 6.090
1.30 0.3088 0.6912 0.3693 7.320
2.00 0.2941 0.7059 0.3483 6.900
4.00 0.2647 0.7353 0.3074 6.094
6.00 0.1985 0.8015 0.2213 4.385
10.00 0.1029 0.8971 0.1086 2.152
Lot #101F-6815: DNA m.w. 16.4 x 106; DNA - P 1.573 x 10
4
M; DNA -
dup 3.12 x M; drug/DNA 4; drug/DNA - dup 2.01 x 10 .
Table 33
Crosslinking Data for 4,9-Dichloro-2-Methyl-2-Azaadamantane
and M. Luteus DNA
Number of
Corrected Crosslinks/
Time Fraction Fraction Number of nucleotide
(x 10"6)(minutes) Crosslinked Un-Crosslinked Crosslinks/DNA
0.50 0.2374 0.7626 0.2710 4.637
1.00 0.2700 0.7300 0.3147 5.385
1.30 0.3451 0.6549 0.4233 7.242
2.00 0.3819 0.6181 0.4811 8.232
2.30 0.4045 0.5944 0.5202 8,901
3.00 0.4126 0.5874 0.5320 9.104
4.00 0.4113 0.5887 0.5298 9.066
6.00 0.3759 0.6241 0.4714 8.067
10.00 0.2411 0.7589 0.2759 4.721
14.00 0.2128 0.7872 0.2393 4.094
Lot #89C-6820j_ DNA m.w. 1.9 x 107; DNA
- P 1.854 x M^DNA -
dup 3.17 x 10 M; drug/DNA 3.45; drug/DNA
- dup 2.01 x 10 .
Homogeneous reactions were performed at
37 C in a total volume of
800 yl buffered with 20 mM potassium phosphate solution at pH equal
to 7 and 0.15 M NaCl.
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